Steven M. Dubinett, MD

Pulmonologist

Conditions Treated

Bio & Insurance Information

Dr. Steven Dubinett graduated the medical school from the Rutgers New Jersey Medical School and did his internship at the UMDNJ-University Hospital. He completed two residency programs, one at the Massachusetts General Hospital and the other at the VA Medical Center and also one fellowship. Dr. Dubinett is specialized in pulmonology and board certified in internal medicine and pulmonary disease. He has been in practice for more than 20 years and is affiliated with the Cedars-Sinai Medical Center and the Ronald Reagan UCLA Medical Center. During his career, he has also contributed to several publications of medical interest.



Education & Training

Rutgers New Jersey Medical School

Medical School

UMDNJ-University Hospital

Internship

VA Medical Center

Residency

Massachusetts General Hospital

Residency

Harvard Medical School

Fellowship

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine - Pulmonary Disease

Hospitals & Clinics

Cedars-Sinai Medical Center

Languages: English/Spanish

(310) 423-3277

8700 Beverly Blvd

Los Angeles, California 90048

Read More

Olive View-UCLA Medical Center

Languages: English/Spanish

(818) 364-1555

14445 Olive View Dr

Sylmar, California 91342

Read More

Ronald Reagan UCLA Medical Center

Languages: English/Spanish

(310) 825-9111

757 Westwood Plaza

Los Angeles, California 90095

Read More

VA Greater Los Angeles Healthcare System

Languages: English/Spanish

(310) 478-3711

11301 Wilshire Blvd

Los Angeles, California 90073

Read More

Publications

Dr. Steven M. Dubinett has contributed to 3 publications.

MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.

Hong, C. S.,Graham, N. A.,Gu, W.,Espindola Camacho, C.,Mah, V.,Maresh, E. L.,Alavi, M.,Bagryanova, L.,Krotee, P. A.,Gardner, B. K.,Behbahan, I. S.,Horvath, S.,Chia, D....; Cell Rep. 2016 Feb 16.

See more >>

Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers.

Momcilovic, M.,McMickle, R.,Abt, E.,Seki, A.,Simko, S. A.,Magyar, C.,Stout, D. B.,Fishbein, M. C.,Walser, T. C.,Dubinett, S. M.,Shackelford, D. B.; Cancer Res.. 2015 Nov 18.

See more >>

Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway.

Lee, M. H.,Kachroo, P.,Pagano, P. C.,Yanagawa, J.,Wang, G.,Walser, T. C.,Krysan, K.,Sharma, S.,John, M. S.,Dubinett, S. M.,Lee, J. M.; J Cancer Sci Ther. 2015 Nov 03.

See more >>